1887
Perspective Open Access
Like 0

Abstract

To tailor a surveillance system to its objectives and to evaluate its fitness for purpose, an accurate description of its structural elements is essential. Existing recommendations for setting up a system seldom offer a comprehensive list of all surveillance elements to be considered. Moreover, there is sometimes confusion in the way terms describing these elements are interpreted. The objective of this paper is to propose a comprehensive set of surveillance system descriptors that can delineate the important elements and clarify the meaning of the terms used. We identified 20 descriptors that we classified in five categories: (i) surveillance scheme; (ii) population and cases; (iii) supplementary data; (iv) information flow; and (v) period of time. We tried to make the definitions of these descriptors as clear and simple as possible to avoid confusion or misinterpretation of the terms used. The relative importance of each element may vary depending on the objectives of the surveillance scheme. Surveillance descriptors should be reviewed periodically to document changes and to assess if the system continues to be fit for purpose. Together with the minimum requirements for variables and the planned outputs for disseminating the data, the surveillance descriptors can be used to define surveillance standards.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.27.1900708
2020-07-09
2020-08-10
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.27.1900708
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/27/eurosurv-25-27-3.html?itemId=/content/10.2807/1560-7917.ES.2020.25.27.1900708&mimeType=html&fmt=ahah

References

  1. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2008.
  2. Porta M. Dictionary of Epidemiology. 6th ed. Oxford: Oxford University Press; 2014.
  3. Langmuir AD. The surveillance of communicable diseases of national importance. N Engl J Med. 1963;268(4):182-92.  https://doi.org/10.1056/NEJM196301242680405  PMID: 13928666 
  4. Groseclose SL, Buckeridge DL. Public Health Surveillance Systems: Recent Advances in Their Use and Evaluation. Annu Rev Public Health. 2017;38(1):57-79.  https://doi.org/10.1146/annurev-publhealth-031816-044348  PMID: 27992726 
  5. Hopkins RS. Design and operation of state and local infectious disease surveillance systems. J Public Health Manag Pract. 2005;11(3):184-90.  https://doi.org/10.1097/00124784-200505000-00002  PMID: 15829830 
  6. European Centre for Disease Prevention and Control (ECDC). Data quality monitoring and surveillance system evaluation: a handbook of methods and applications. Stockholm: ECDC; 24 Sep 2014. Available from: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/Data-quality-monitoring-surveillance-system-evaluation-Sept-2014.pdf
  7. German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN, Guidelines Working Group Centers for Disease Control and Prevention (CDC). Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50(RR-13):1-35, quiz CE1-7. PMID: 18634202 
  8. World Health Organization (WHO). Surveillance standards for vaccine-preventable diseases. 2nd ed. Geneva: WHO; 2018. Available from: https://apps.who.int/iris/handle/10665/275754
  9. Paquet C, Coulombier D, Kaiser R, Ciotti M. Epidemic intelligence: a new framework for strengthening disease surveillance in Europe. Euro Surveill. 2006;11(12):212-4.  https://doi.org/10.2807/esm.11.12.00665-en  PMID: 17370970 
  10. European Centre for Disease Prevention and Control (ECDC). Surveillance systems overview for 2017. Stockholm: ECDC; 7 Dec 2018. Available from: https://ecdc.europa.eu/en/publications-data/surveillance-systems-overview-2017
  11. Hampton LM, Zell ER, Schrag S, Cohen AL. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ. 2012;90(8):568-77.  https://doi.org/10.2471/BLT.11.098178  PMID: 22893740 
  12. Spiteri G, Sudre B, Septfons A, Beauté J, The European Zika Surveillance Network. Surveillance of Zika virus infection in the EU/EEA, June 2015 to January 2017. Euro Surveill. 2017;22(41).  https://doi.org/10.2807/1560-7917.ES.2017.22.41.17-00254  PMID: 29043960 
  13. Bijkerk P, Fanoy EB, Kardamanidis K, van der Plas SM, Te Wierik MJ, Kretzschmar ME, et al. To notify or not to notify: decision aid for policy makers on whether to make an infectious disease mandatorily notifiable. Euro Surveill. 2015;20(34):30003.  https://doi.org/10.2807/1560-7917.ES.2015.20.34.30003  PMID: 26530302 
  14. Beauté J, Broberg E, Plata F, Bonmarin I, O Donnell J, Delgado C, et al. Overrepresentation of influenza A(H1N1)pdm09 virus among severe influenza cases in the 2011/12 season in four European countries. Euro Surveill. 2012;17(9):20105.  https://doi.org/10.2807/ese.17.09  PMID: 22401564 
  15. Sahni V, Scott AN, Beliveau M, Varughese M, Dover DC, Talbot J. Public health surveillance response following the southern Alberta floods, 2013. Can J Public Health. 2016;107(2):e142-8.  https://doi.org/10.17269/cjph.107.5188  PMID: 27526210 
  16. Ricchizzi E, Latour K, Kärki T, Buttazzi R, Jans B, Moro ML, et al. Antimicrobial use in European long-term care facilities: results from the third point prevalence survey of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill. 2018;23(46).  https://doi.org/10.2807/1560-7917.ES.2018.23.46.1800394  PMID: 30458913 
  17. Suetens C, Latour K, Kärki T, Ricchizzi E, Kinross P, Moro ML, et al. Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016 to 2017. Euro Surveill. 2018;23(46).  https://doi.org/10.2807/1560-7917.ES.2018.23.46.1800516  PMID: 30458912 
  18. Rizzo C, Napoli C, Venturi G, Pupella S, Lombardini L, Calistri P, et al. West Nile virus transmission: results from the integrated surveillance system in Italy, 2008 to 2015. Euro Surveill. 2016;21(37):30340.  https://doi.org/10.2807/1560-7917.ES.2016.21.37.30340  PMID: 27684046 
  19. Nisalak A, Clapham HE, Kalayanarooj S, Klungthong C, Thaisomboonsuk B, Fernandez S, et al. Forty Years of Dengue Surveillance at a Tertiary Pediatric Hospital in Bangkok, Thailand, 1973-2012. Am J Trop Med Hyg. 2016;94(6):1342-7.  https://doi.org/10.4269/ajtmh.15-0337  PMID: 27022151 
  20. European Centre for Disease Prevention and Control (ECDC). Chlamydia infection. In: ECDC Annual epidemiological report for 2017. Stockholm: ECDC; 2019. Available from: https://ecdc.europa.eu/sites/portal/files/documents/chlamydia-infection-annual-epidemiological-report-2017.pdf
  21. Collin SM, de Vries G, Lönnroth K, Migliori GB, Abubakar I, Anderson SR, et al. Tuberculosis in the European Union and European Economic Area: a survey of national tuberculosis programmes. Eur Respir J. 2018;52(6):1801449.  https://doi.org/10.1183/13993003.01449-2018  PMID: 30309977 
  22. Saunders MJ, Tovar MA, Collier D, Baldwin MR, Montoya R, Valencia TR, et al. Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study. Lancet Infect Dis. 2019;19(5):519-28.  https://doi.org/10.1016/S1473-3099(18)30753-9  PMID: 30910427 
  23. Lytras T, Spala G, Bonovas S, Panagiotopoulos T. Evaluation of tuberculosis underreporting in Greece through comparison with anti-tuberculosis drug consumption. PLoS One. 2012;7(11):e50033.  https://doi.org/10.1371/journal.pone.0050033  PMID: 23185524 
  24. Beauté J, The European Legionnaires’ Disease Surveillance Network. Legionnaires’ disease in Europe, 2011 to 2015. Euro Surveill. 2017;22(27).  https://doi.org/10.2807/1560-7917.ES.2017.22.27.30566  PMID: 28703097 
  25. Moran-Gilad J. Whole genome sequencing (WGS) for food-borne pathogen surveillance and control - taking the pulse. Euro Surveill. 2017;22(23):30547.  https://doi.org/10.2807/1560-7917.ES.2017.22.23.30547  PMID: 28661389 
  26. Giesecke J. Modern infectious disease epidemiology. 3rd ed. Boca Raton: CRC Press; 2017.
/content/10.2807/1560-7917.ES.2020.25.27.1900708
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error